Brazilian AI Delegation Visits Synyi AI for Insightful Exchange
On the morning of July 9, under the guidance of the Shanghai Science and Technology Innovation Center and organized by Shanghai Pudong Software Park Venture Capital Management Co., Ltd., a Brazilian artificial intelligence delegation visited Synyi AI for an in-depth study and exchange. The delegation included scholars from key Brazilian government and research institutions such as the National Data Processing Service Bureau, the Federal Center for Technological Education, the National Laboratory for Scientific Computing under the Ministry of Science, Technology and Innovation, and the Federal University of Uberlândia. The two sides engaged in dynamic discussions covering industry trends in healthcare, the integration of intelligent technologies in medical services, and prospects for future development. The visit was accompanied by Ms. Zheng Bi, Director of the International Cooperation Department of the Shanghai Science and Technology Entrepreneurship Center, and Mr. Guo Bin, General Manager of Shanghai Pudong Software Park Venture Capital Management Co., Ltd.
Representatives from Synyi AI’s Strategic Marketing and Product Solution departments also participated in the exchange.
Following the introduction of Synyi AI’s core product portfolio, Mr. Tianyang Fan, Deputy Consul General of the Brazilian Consulate in Shanghai, expressed strong appreciation for the company's innovation and technological leadership in smart healthcare solutions. He conveyed hopes for further collaboration and knowledge exchange, especially in integrating AI technologies into practical medical scenarios to advance global healthcare.
As artificial intelligence continues to advance globally, Synyi AI, one of China’s leading AI enterprises, is expanding its international reach. With technological innovation and professional services as its competitive advantages, Synyi AI remains committed to meeting user needs and applying cutting-edge AI to healthcare, aiming to deliver more efficient and personalized experiences for patients worldwide.